Attitudes of patients with schizophrenia toward taking medication (original) (raw)
Related papers
Folia Medica, 2012
OBJECTIVE: Attitude toward antipsychotic medication is considered as one of the main predictors for medication adherence in schizophrenia. The present non-interventional crosssectional study aims to explore the associations between attitudes toward antipsychotic medication, insight and other clinical variables in outpatients with schizophrenia. METHOD: Attitudes toward antipsychotic medication, clinical and social variables, sociodemographic and illness-related characteristics were assessed via a set of semi-structured clinical interviews and self-rating scales in a total of 226 patients with schizophrenia on a long-term antipsychotic treatment in community based settings. The associations between attitudes toward medication and severity of psychopathology, insight and medication side effects were examined. RESULTS: The greater hospitalization rate in the previous year was associated with more severe psychopathology at the time of the study, more pronounced side effects of the thera...
Schizophrenia Research, 2016
To investigate the interest in the attitudes toward antipsychotic medication in exploring medication non-adherence. Methods: Schizophrenic patients (N = 120) completed the Beliefs about Medicines Questionnaire and measures of medication adherence, and clinical outcomes. Comparison between four attitudinal groups and logistic regressions were performed. Results: High level of adherence varied significantly between attitudinal groups (Accepting, 70%; Indifferent, 63%; Ambivalent, 50%; Sceptical, 14%; p b 0.001). Poor insight and psychic side effects were the most significant predictors of negative beliefs. Conclusion: The attitudinal groups approach could facilitate the identification of patients with non-adherence and determine individual targets of interventions to improve negative beliefs.
ATTITUDE TOWARD TREATMENT IN SCHIZOPHRENIA: INFLUENCES OF COGNITIVE DIMENSIONS
Object: This study aimed to explore the clinical, psychopathological, neuropsychological and awareness of illness correlates associated with attitude towards pharmacological treatment in a group of inpatients with diagnosis of chronic schizophrenia Method: 50 schizophrenic inpatients were evaluated with PANSS to assess psychopathology , a neurocognitive battery, the Brief Assessment of Cognition in Schizophrenia (BACS, Keefe 1999), the Scale for Unawareness of Mental Disease to assess awareness of illness and the Drug Attitude Inventory .
Journal of Clinical Nursing, 2011
Aims and objectives. This research aimed to: (i) investigate the prevalence and perceived severity of antipsychotic side effects in people with schizophrenia and related disorders living in communities in Singapore; (ii) examine the relationship between antipsychotic variables (type, dose, route, prescription duration) and side effects; and (iii) examine the relationship between side effects and attitudes towards medication. Background. Antipsychotics are the mainstay treatment in schizophrenia and other psychotic disorders. However, antipsychotics are associated with a wide range of side effects, which potentially have adverse effects on patients' functioning. A lack of studies comparing the frequency of side effects and their associated levels of distress across multiple antipsychotics and different medication variables has been noted. Additionally, it is essential to assess patients' attitudes towards antipsychotics in relation to their experience of side effects. Design. A cross-sectional, non-experimental research design was used. Method. A convenience sample of 96 adults with schizophrenia and related disorders on antipsychotic treatment and attending the hospital's outpatient clinic was recruited. Variables collected included antipsychotic type, dose, route, prescription duration and side effects, attitudes towards medication and demographic and clinical variables. They were analysed with descriptive statistics and correlational analyses. Results. Many participants experienced psychic (80AE2%), extrapyramidal (69AE8%) and miscellaneous side effects (61AE5%). Side effects positively correlated with dose (p = 0AE016) and negatively correlated with prescription duration (p = 0AE014). Negative attitudes towards medication were positively correlated with side effects in general (p = 0AE023), along with hormonal (p = 0AE013) and psychic side effects (p = 0AE008). Conclusion. Findings revealed that majority of the participants experienced and were distressed over psychic, extrapyramidal and weight gain, which may be related to high doses and treatment duration. Additionally, patients experiencing psychic and hormonal side effects are at risk of developing negative attitudes towards medication. Relevance to clinical practice. Findings guide the development of appropriate nursing interventions that aim to alleviate side effects, reduce negative attitudes towards medication and prevent compliance problems.
Attitudes of Medical and Pharmacy Students Towards Patients Suffering from Schizophrenia
Serbian Journal of Experimental and Clinical Research, 2017
Research over the past twenty years has shown that the attitudes of health care workers and students towards people who are suffering from schizophrenia have become more negative. The aim of our study was to investigate the attitudes of medical and pharmacy students towards patients with schizophrenia and explore the differences in attitudes between study groups and students in different years. Materials and methods: Second- and fifth-year medical and pharmacy students from the Faculty of Medical Sciences at the University of Kragujevac were included in an observational, prospective, cross-sectional study. The sample consisted of 113 students from the pharmacy and medical schools who were chosen via random sampling. The students completed a two-part questionnaire. Th e first part contained questions about sociodemographic characteristics, whereas the second part was a translated version of the Mental Illness: Clinician’s Attitudes (MICA) v4 scale. Results: There is a statistically s...
Indian Journal of Psychological Medicine 2014;36: 288-293
Background: Given the paucity of research in this area, this study attempted to assess attitudes toward antipsychotic medications and its correlates among patients with schizophrenia, either on first-generation antipsychotics (FGAs) or second-generation antipsychotics (SGAs) medications. Materials and Methods: Structured assessments of attitudes to antipsychotics, psychopathology, insight and side-effects were carried out in 120 patients with DSM-IV schizophrenia; 89 of these were on SGAs and 31 on FGAs. Results: Patients had predominantly positive attitudes toward antipsychotics. Severity of side-effects was the principal correlate of attitudes, explaining 19.5% of the variance, followed by greater insight (4.2% of the variance). Other factors such as younger age, male gender, employment, higher family income, urban residence and lower symptom-severity explained only a negligible proportion of the variance (0.2%) in attitudes. Patients on SGAs had more positive views of their medications than those on FGAs. They felt more normal on their medications, believed that their thoughts were clearer on medications, felt that good things about their medications outweighed the bad and believed that their medications helped them from falling ill again. In addition, they did not feel as tired and sluggish on their medications and did not believe that medications were unnatural or controlled their bodies. Conclusions: Positive attitudes toward antipsychotics were common among patients with schizophrenia. Attitudes were principally determined by severity of side-effects and insight levels. Patients on SGAs had better attitudes, possibly because of less severe side-effects and greater insight among them. The importance of exploring patients’ attitudes toward their antipsychotics is highlighted by this study.
Mental Illness, 2009
Neuroleptic non-compliance remains a serious challenge for the treatment of psychosis. Non-compliance is predominantly attributed to side effects, lack of illness insight, reduced well-being or poor therapeutic alliance. However, other still neglected factors may also play a role. Further, little is known about whether psychiatric patients without psychosis who are increasingly prescribed neuroleptics differ in terms of medication compliance or about reasons for non-compliance by psychosis patients. As direct questioning is notoriously prone to social desirability biases, we conducted an anonymous survey. After a strict selection process blind to results, 95 psychiatric patients were retained for the final analyses (69 participants with a presumed diagnosis of schizophrenia psychosis, 26 without psychosis). Self-reported neuroleptic non-compliance was more prevalent in psychosis patients than non-psychosis patients. Apart from side effects and illness insight, main reasons for non-compliance in both groups were forgetfulness, distrust in therapist, and no subjective need for treatment. Other notable reasons were stigma and advice of relatives/acquaintances against neuroleptic medication. Gain from illness was a reason for non-compliance in 11-18% of the psychosis patients. Only 9% of all patients reported no side effects and full compliance and at the same time acknowledged that neuroleptics worked well for them. While pills were preferred over depot injections by the majority of patients, depot was judged as an alternative by a substantial subgroup. Although many patients acknowledge the need and benefits of neuroleptic medication, non-compliance was the norm rather than the exception in our samples.
Attitude towards Treatment in Persons with Schizophrenia and Mood Disorders
2020
Mental illness is a long term disease process and medication non-adherence is a common and complex barrier to effective long-term treatment. Non adherence is the main cause of relapse and rehospitalization. So, finding out the attitude towards the treatment could help in the planning of proper management strategies. Thus, the present study was undertaken to assess the attitude towards treatment in patient with Schizophrenia and Mood Disorders. A descriptive research design was used for the study. Population consists of follow up patients in OPD who were already diagnosed as Schizophrenia and Mood disorders patients under ICD-10 criteria by the psychiatrist. Using purposive sampling technique, 50 patients each diagnosed with Schizophrenia and Mood disorders were selected. After taking written informed consent, socio-demographic and clinical variables data sheet and Drug attitude inventory (DAI) -30 items were used to collect the data. The collected data were analyzed with statistical...
Beliefs About Illness of Patients with Schizophrenia
Journal of Postgraduate Medical Institute, 2015
Objective: To elicit the beliefs and perception of patients with schizophrenia about their illness by using Short Explanatory Model Interview (SEMI). Methodology: This cross sectional study was conducted in the department of psychiatry, Lady Reading Hospital. One hundred and three patients of schizophrenia were included in the study. Short explanatory model Interview (SEMI) was used to assess the explanatory model of illness of the sample. Four major areas covered in SEMI were “Concept” i.e., naming the illness, “Cause”, “Treatment Choice” i.e., help seeking behaviour, and “Severity” of the illness. Results: Mean age of the sample was 30.52 ± 9.41 years. Regarding Concept, 34(33%) patients who although couldn’t name any but attributed their condition to mental illness. The major response to the cause for the development of schizophrenia was stress of social issues by 22(23.30%) patients. A total of 56(54.3%) patients reported a combination of medication & spiritual healer to be the ...